Considering the Term “Cancer Survivor” A study investigates how people who have been diagnosed with cancer feel about being called survivors. by Jen Tota McGivney Making Clinical Trials More Inclusive Broadening clinical trial eligibility criteria to include cancer patients who also have other health conditions could increase trial enrollment. by Ashley P. Taylor The Education of a Patient Advocate Bob Riter explains how his breast cancer diagnosis set him on a path to find his calling. by Bob Riter Survivor Profile The Bridge Builder Breast cancer survivor Bob Riter forges connections among people affected by all types of cancer. by Marci A. Landsmann Policy Matters Public Funding is the Lifeblood of Cancer Research Let your voice be heard in support of robust, sustained and predictable federal funding increases. by George D. Demetri, MD Reinforcements for Cancer Research Scientific meeting emphasizes the importance of patient advocates in helping researchers to reduce cancer health disparities. by Marci A. Landsmann An Uncommon Partnership Through the Angiosarcoma Project, researchers are partnering with patients to learn about a rare cancer. by Ashley P. Taylor POLICY MATTERS A Growing Commitment to Cancer Survivors The number of cancer survivors is growing. We must step up efforts to meet their needs. by Elizabeth M. Jaffee, MD Survivor Profile The Power of Patients Janet Freeman-Daily helps put patients at the center of lung cancer research. by Robin Meadows Raising Their Voices People with metastatic breast cancer are demanding to be seen, counted and included in breast cancer research. by Sue Rochman next Cancer Talk Considering the Term “Cancer Survivor” A study investigates how people who have been diagnosed with cancer feel about being called survivors. by Jen Tota McGivney Making Clinical Trials More Inclusive Broadening clinical trial eligibility criteria to include cancer patients who also have other health conditions could increase trial enrollment. by Ashley P. Taylor What Do Clinical Trial Endpoints Really Measure? A study investigates whether a commonly used clinical trial endpoint, progression-free survival, can be used to predict quality of life. by Jon Kelvey Shingles Risk Increased for Cancer Patients A new vaccine is safe for cancer patients but hard to find. by Nancy Averett More Posts